MARKET

PAVM

PAVM

Pavmed
NASDAQ
0.6201
+0.0101
+1.66%
Closed 19:59 12/07 EST
OPEN
0.5900
PREV CLOSE
0.6100
HIGH
0.6382
LOW
0.5900
VOLUME
720.25K
TURNOVER
--
52 WEEK HIGH
3.660
52 WEEK LOW
0.5795
MARKET CAP
58.11M
P/E (TTM)
-0.6033
1D
5D
1M
3M
1Y
5Y
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
NEW YORK, December 01, 2022--Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), today announced that Suman M. Ve...
Business Wire · 6d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 11/24 21:31
BRIEF-PAVmed Provides Third Quarter 2022 Financial Results
Reuters · 11/15 22:14
PAVmed GAAP EPS of -$0.29
Seekingalpha · 11/15 21:37
PAVmed Q3 EPS $(0.15) Beats $(0.26) Estimate, Sales $76.00K Miss $230.00K Estimate
Benzinga · 11/15 21:21
PAVmed Q3 Net Loss Widens, Revenue Declines
PAVmed Q3 Net Loss Widens, Revenue Declines
MT Newswires · 11/15 17:00
Notable earnings after Tuesday's close
Seekingalpha · 11/14 22:35
BRIEF-Lucid Diagnostics Inc Reports Quarterly Adjusted Loss Per Share Of $0.28
Reuters · 11/14 22:21
More
About PAVM
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through four divisions: Medical Devices, Diagnostics, Digital Health and Emerging Innovations. Its Medical Devices division includes CarpX Minimally Invasive Surgical Device for Carpal Tunnel Syndrome, Infusion Therapy - PortIO Implantable Intraosseous Vascular Access Device and NextFlo Disposable Intravenous Infusion Platform Technology. Its Diagnostics division includes EsoGuard Esophageal DNA Laboratory Developed Test, EsoCheck Esophageal Cell Collection Device, and EsoCure Esophageal Ablation Device with Caldus Technology. Its Digital Health division includes Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics. Its Emerging Innovations division includes NextVent ventilators, FlexMO medical circulatory support cannulas, Veris Cardiac Monitor, DisappEAR resorbable pediatric ear tubes and Solys glucose monitoring.

Webull offers kinds of PAVmed Inc stock information, including NASDAQ:PAVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PAVM stock methods without spending real money on the virtual paper trading platform.